Skip to main
HLF

Herbalife (HLF) Stock Forecast & Price Target

Herbalife (HLF) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Herbalife is making gradual progress on margin recovery, with underlying Q2/26 adjusted EBITDA in line with expectations and gross margin pressure easing sequentially. Despite challenges in the operating environment, management remains committed to delivering low-single digit sales volume growth for 2026. Potential catalysts for the stock include accretive M&A and an improvement in the macro backdrop, while risks include execution/dilution risk associated with additional acquisitions and supply disruptions across key species.

Bears say

Herbalife is facing significant risks to its long-term performance due to its reliance on a direct-selling business model and the potential for increased regulatory scrutiny surrounding the health and wellness industry. Additionally, the company's heavy focus on weight management products leaves it vulnerable to shifts in consumer preferences and the potential for increased competition. Financially, the company's ongoing supply chain challenges and economic headwinds, particularly in emerging markets, could impact its growth and profitability in the near-term.

Herbalife (HLF) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Herbalife and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Herbalife (HLF) Forecast

Analysts have given Herbalife (HLF) a Buy based on their latest research and market trends.

According to 4 analysts, Herbalife (HLF) has a Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Herbalife (HLF)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.